Sulzer D, St Remy C, Rayport S
Department of Psychiatry, Columbia University, New York, New York 10032, USA.
Mol Pharmacol. 1996 Feb;49(2):338-42.
Although amphetamine releases catecholamines from isolated secretory vesicles, a number of in vivo experiments have indicated that the vesicular amine transport blocker reserpine does not block amphetamine-induced release. To address this paradox, we examined the effect of reserpine on amphetamine-induced dopamine release from postnatal ventral midbrain neurons in culture. These cultures provide a preparation in which intracellular, extracellular, and releasable dopamine pools can be measured simultaneously. We found that 1 microM reserpine for 90 min reduced stimulation-dependent dopamine release by > 95%. In parallel, reserpine reduced amphetamine-induced dopamine release by > 95% compared with cells not exposed to reserpine or by 75% compared with reserpine-treated cultures. This shows that amphetamine acts principally by redistributing dopamine from synaptic vesicles to the cytosol.
虽然苯丙胺能从分离的分泌囊泡中释放儿茶酚胺,但一些体内实验表明,囊泡胺转运阻滞剂利血平并不阻断苯丙胺诱导的释放。为了解决这一矛盾,我们研究了利血平对培养的新生腹侧中脑神经元中苯丙胺诱导的多巴胺释放的影响。这些培养物提供了一种可同时测量细胞内、细胞外和可释放多巴胺池的制剂。我们发现,1微摩尔利血平处理90分钟可使刺激依赖性多巴胺释放减少>95%。同时,与未接触利血平的细胞相比,利血平使苯丙胺诱导的多巴胺释放减少>95%,与利血平处理的培养物相比减少75%。这表明苯丙胺主要通过将多巴胺从突触囊泡重新分布到胞质溶胶起作用。